Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
126.36
+1.41 (1.13%)
At close: Nov 7, 2025, 4:00 PM EST
126.27
-0.09 (-0.07%)
After-hours: Nov 7, 2025, 7:52 PM EST
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of $219.72 billion as of November 7, 2025. Its market cap has increased by 7.93% in one year.
Market Cap
219.72B
Enterprise Value
224.97B
1-Year Change
7.93%
Ranking
Category
Stock Price
$126.36
Market Cap Chart
Since December 1, 1998, Abbott Laboratories's market cap has increased from $72.66B to $219.72B, an increase of 202.38%. That is a compound annual growth rate of 4.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 219.72B | 12.00% |
| Dec 31, 2024 | 196.18B | 2.67% |
| Dec 29, 2023 | 191.09B | -0.18% |
| Dec 30, 2022 | 191.43B | -23.08% |
| Dec 31, 2021 | 248.87B | 28.25% |
| Dec 31, 2020 | 194.06B | 26.33% |
| Dec 31, 2019 | 153.61B | 20.92% |
| Dec 31, 2018 | 127.04B | 27.88% |
| Dec 29, 2017 | 99.34B | 75.66% |
| Dec 30, 2016 | 56.55B | -15.59% |
| Dec 31, 2015 | 66.99B | -1.18% |
| Dec 31, 2014 | 67.79B | 14.39% |
| Dec 31, 2013 | 59.27B | -42.76% |
| Dec 31, 2012 | 103.53B | 18.20% |
| Dec 30, 2011 | 87.59B | 18.28% |
| Dec 31, 2010 | 74.06B | -11.31% |
| Dec 31, 2009 | 83.51B | 0.85% |
| Dec 31, 2008 | 82.81B | -4.56% |
| Dec 31, 2007 | 86.77B | 16.06% |
| Dec 29, 2006 | 74.76B | 22.23% |
| Dec 30, 2005 | 61.16B | -15.81% |
| Dec 31, 2004 | 72.65B | -0.27% |
| Dec 31, 2003 | 72.85B | 16.56% |
| Dec 31, 2002 | 62.50B | -27.79% |
| Dec 31, 2001 | 86.55B | 15.52% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 827.67B |
| Johnson & Johnson | 449.50B |
| AbbVie | 387.34B |
| UnitedHealth Group | 293.68B |
| AstraZeneca | 263.38B |
| Novartis AG | 243.48B |
| Thermo Fisher Scientific | 215.06B |
| Merck & Co. | 214.15B |